University of Bristol

Exonate

Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a protein called Vascular Endothelial Growth Factor (VEGF), they have demonstrated that they could not only treat models of angiogenic disease (eg Cancer and wet AMD) but also protect kidney and nerve cells while simultaneously […]

Micrima

Micrima has developed an imaging system that exploits differences in permittivity – the ability of a substance to store electrical energy in an electric field – to identify and locate lesions in breast tissue. The company intends to develop and commercialise a new Breast Imaging System (MARIA) aimed at radically improving breast cancer detection and survival […]

Itaconix plc

Revolymer, spun-out from Bristol University, has 2 core technologies based on amphiphilic polymers & encapsulation which have evolved into 4 platforms leading to multiple uses.